Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Low-intensity ultrasound may help protect hair follicles from chemotherapy-induced hair loss.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

The committee decided not to approve the drug due to low effectiveness and high risks.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Scalp cooling therapy is costly and often not covered by insurance, limiting access for low-income patients.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Aumolertinib effectively controls lung cancer and improves quality of life.

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

Repurposing existing drugs can improve cancer treatment but faces challenges.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Image analysis can effectively identify changes in scalps affected by chemotherapy-induced hair loss.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Better awareness of chemotherapy's side effects improves self-care.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.